GT BIOPHARMA, INC. Convertible Debt, Current
GT BIOPHARMA, INC. (GTBP) had Convertible Debt, Current of $0 as of 2021-09-30, per its 10-Q filed 2021-11-10.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Debt, Current › Long-Term Debt, Current Maturities
us-gaap:ConvertibleDebtCurrent · last filed 2022-03-28
- 2021-09-30: Convertible Debt, Current $0.00.
- 2021-06-30: Convertible Debt, Current $0.00.
- 2021-03-31: Convertible Debt, Current $0.00.
- 2020-12-31: Convertible Debt, Current $26.30M.
| Period end | Convertible Debt, Current | Convertible Debt, Current as first filed |
|---|---|---|
| 2021-09-30 | $0.00 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $0.00 10-Q/A · filed 2021-12-29 | |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $26.30M 10-K · filed 2022-03-28 | |
| 2020-09-30 | $23.00M 10-Q · filed 2020-11-13 | |
| 2020-06-30 | $21.84M 10-Q/A · filed 2020-08-18 | |
| 2020-03-31 | $13.26M 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $13.21M 10-K · filed 2021-04-16 | |
| 2019-09-30 | $13.14M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $12.17M 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $11.30M 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $10.67M 10-K · filed 2020-03-27 | |
| 2018-09-30 | $10.60M 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $6.86M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $2.93M 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $0.00 10-K · filed 2019-03-29 | |
| 2017-09-30 | $0.00 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $844.00K 10-Q · filed 2017-08-11 | |
| 2017-03-31 | $844.00K 10-Q · filed 2017-04-28 | |
| 2016-12-31 | $10.35M 10-K · filed 2018-03-01 | $889.00K 10-K · filed 2017-03-31 |
| 2016-09-30 | $1.04M 10-Q/A · filed 2018-02-28 | |
| 2016-06-30 | $1.04M 10-Q/A · filed 2018-02-28 | |
| 2016-03-31 | $1.04M 10-Q/A · filed 2018-02-28 | |
| 2015-12-31 | $1.04M 10-K/A · filed 2018-02-28 | |
| 2015-09-30 | $547.00K 10-Q · filed 2015-11-13 | |
| 2015-06-30 | $547.00K 10-Q · filed 2015-08-14 | |
| 2015-03-31 | $547.00K 10-Q · filed 2015-05-14 | |
| 2014-12-31 | $547.00K 10-K/A · filed 2018-02-28 | |
| 2014-09-30 | $547.00K 10-Q · filed 2015-01-08 | |
| 2014-06-30 | $547.00K 10-Q · filed 2015-01-08 | |
| 2014-03-31 | $547.00K 10-Q · filed 2015-01-08 | |
| 2013-12-31 | $547.00K 10-K · filed 2015-03-31 | |
| 2013-09-30 | $547.00K 10-Q · filed 2014-12-17 | |
| 2013-06-30 | $547.00K 10-Q · filed 2014-12-12 | |
| 2013-03-31 | $547.00K 10-Q · filed 2014-12-10 | |
| 2012-12-31 | $625.00K 10-K · filed 2015-01-08 | |
| 2012-09-30 | $625.00K 10-Q · filed 2012-11-21 | |
| 2012-06-30 | $747.00K 10-Q/A · filed 2012-09-13 | |
| 2012-03-31 | $942.00K 10-Q · filed 2012-05-21 | |
| 2011-12-31 | $995.00K 10-K · filed 2014-11-18 | |
| 2011-09-30 | $1.14M 10-Q · filed 2011-11-21 | |
| 2011-06-30 | $1.20M 10-Q/A · filed 2011-09-12 | |
| 2010-12-31 | $1.54M 10-K · filed 2012-04-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |